← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Deferasirox currently has availability issues reported in 4 European registers: Austria, Spain, Italy, Sweden.
Shortage ATC — · also listed as: DEFERASIROX · data refreshed 8 September 2026
As of 8 September 2026, 4 of the 9 tracked registers list current availability issues for Deferasirox, covering 11 affected product presentations. The longest-running open report was filed in Italy on 2022-12-21 and has now been open for about 45 months. Where agencies state a cause, manufacturing problems lead with 4 of the 7 stated-cause reports, followed by unexpectedly high demand with 2. The furthest expected-resolution date currently on file is 2026-10-04; the earliest is 2026-09-29. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2022-12-21), with Spain following roughly 40 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Deferasirox G.L. 360 mg-Filmtabletten | 2024-04-16 | — | — | register ↗ |
| 🇪🇸 Spain | Shortage DEFERASIROX AUROVITAS 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos + 1 more productsDEFERASIROX VISO FARMACEUTICA 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Al/PVC/PVDC) | 2026-04-23 | 2026-10-04 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage DEFERASIROX ABDI + 6 more productsDEFERASIROX ACCORD DEFERASIROX AUROBINDO DEFERASIROX SUN DEFERASIROX ZENTIVA DEFERASIROX ZENTIVA EXJADE | 2022-12-21 | 2026-08-31 | Elevata richiesta: distribuzione contingentata Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Deferasirox Mylan 360 mg Filmdragerad tablett | 2025-07-28 | 2026-10-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Deferasirox in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | EXJADE | Shortage | 2027-01-01 | — | Cessata commercializzazione definitiva |
| 🇪🇸 ES | DEFERASIROX AUROVITAS 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, | Shortage | 2026-08-05 | 2026-10-04 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | DEFERASIROX ZENTIVA | Shortage | 2026-06-05 | — | Problemi produttivi |
| 🇪🇸 ES | DEFERASIROX VISO FARMACEUTICA 90 MG COMPRIMIDOS RECUBIERTOS CON PELICU | Shortage | 2026-04-23 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | DEFERASIROX AUROBINDO | Shortage | 2025-12-07 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | DEFERASIROX ABDI | Shortage | 2025-10-29 | 2026-08-31 | Elevata richiesta: distribuzione contingentata |
| 🇮🇹 IT | DEFERASIROX ACCORD | Shortage | 2025-08-14 | — | Problemi produttivi |
| 🇸🇪 SE | Deferasirox Mylan 360 mg Filmdragerad tablett | Shortage | 2025-07-28 | 2026-10-01 | |
| 🇮🇹 IT | DEFERASIROX SUN | Shortage | 2025-07-02 | — | Problemi produttivi |
| 🇦🇹 AT | Deferasirox G.L. 360 mg-Filmtabletten | Limited availability | 2024-04-16 | — | |
| 🇮🇹 IT | DEFERASIROX ZENTIVA | Shortage | 2022-12-21 | — | Elevata richiesta: distribuzione contingentata |
Yes. As of 8 September 2026, availability issues are reported in: Austria, Spain, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2026-10-04. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
10 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Deferasirox: BASG (Austria), AEMPS CIMA (Spain), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Deferasirox — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/deferasirox/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Deferasirox availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/deferasirox/">Deferasirox shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>